ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CYTK Cytokinetics Inc

70.56
-0.85 (-1.19%)
Last Updated: 15:43:52
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,144,903
Bid Price 70.51
Ask Price 70.57
News -
Day High 71.855

Low
25.98

52 Week Range

High
110.25

Day Low 69.96
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.85 -1.19% 70.56 15:43:52
Open Price Low Price High Price Close Price Prev Close
71.41 69.96 71.855 71.41
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,922 1,144,903 $ 70.93 $ 81,202,670 - 25.98 - 110.25
Last Trade Time Type Quantity Stock Price Currency
15:43:52 20 $ 70.6109 USD

Cytokinetics (CYTK) Options Flow Summary

Overall Flow

Bearish

Net Premium

-1,000k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Cytokinetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.25B 103.00M - 7.53M -526.24M -5.11 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cytokinetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CYTK Message Board. Create One! See More Posts on CYTK Message Board See More Message Board Posts

Historical CYTK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week67.9074.679965.1369.742,093,7422.663.92%
1 Month73.8675.0361.3366.633,147,155-3.30-4.47%
3 Months87.00110.2561.3381.453,514,647-16.44-18.90%
6 Months29.81110.2525.9866.762,930,27440.75136.70%
1 Year34.36110.2525.9859.591,880,95336.20105.36%
3 Years23.69110.2517.7247.281,390,02946.87197.85%
5 Years8.24110.257.0138.201,179,92662.32756.31%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Your Recent History

Delayed Upgrade Clock